| Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment (NCT00929903) | National Cancer Institute (NCI) | 2009-06-01 |
| A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies (NCT00871559) | Regeneron Pharmaceuticals | 2009-06-01 |
| Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation (NCT00948753) | Abramson Cancer Center at Penn Medicine | 2009-06-01 |
| STAT3 Inhibitor for Solid Tumors (NCT00955812) | M.D. Anderson Cancer Center | 2009-06-01 |
| Study to Investigate the Safety, Tolerability and Pharmacokinetics of AD 452 [(+)-Mefloquine] Compared With Racemic Mefloquine (NCT00931697) | Treague Ltd | 2009-06-01 |
| An Exploratory Study to Assess the Effects of JNJ-39439335 on the Relief of Pain Using a Thermal-Grill Experimental Model (NCT01006304) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-06-01 |
| Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A) (NCT00899470) | AstraZeneca | 2009-06-01 |
| A Bioequivalence Study Of 8 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects (NCT00902681) | Pfizer | 2009-06-01 |
| Doripenem Intrapulmonary Pharmacokinetics in Healthy Adult Subjects (NCT00925392) | Keith A. Rodvold | 2009-06-01 |
| A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children. (NCT00905489) | Boehringer Ingelheim | 2009-06-01 |
| Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2 (NCT00931372) | Sanofi | 2009-06-01 |
| A Pilot Study of Renal Hypothermia During Partial Nephrectomy (NCT00888641) | Mayo Clinic | 2009-06-01 |
| At What Time Therapeutic Plasma Concentrations of Paracetamol Are Achieved in Two Marketed Formulations (NCT01551836) | GlaxoSmithKline | 2009-06-01 |
| Toll-like Receptor (TLR) Ligand Matured Dendritic Cell Vaccination in Melanoma Patients (NCT00940004) | Radboud University Medical Center | 2009-06-01 |
| Using Functional MRI to Evaluate Cognitive Behavioral Therapy Treatment Response in Adults With Chronic Pain (NCT00796536) | University of Vermont | 2009-06-01 |
| Compression Anastomosis Using the Compression Anastomotic Ring-locking Procedure (CARP) (NCT01451008) | Region Skane | 2009-06-01 |
| Comparative Formulation Study of Vabicaserin (NCT00928551) | Wyeth is now a wholly owned subsidiary of Pfizer | 2009-06-01 |
| Study Comparing Gelatine Capsule 40 mg D961H and HPMC Capsule in Japanese Healthy Males (NCT00930215) | AstraZeneca | 2009-06-01 |
| A Study to Determine the Metabolism and Elimination of 14C-E7080 in Patients With Advanced Solid Tumors or Lymphomas, Who Are Unsuitable For, or Have Failed, Existing Therapies. (NCT02578316) | Eisai Inc. | 2009-06-01 |
| Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir (NCT00931281) | Abbott | 2009-06-01 |
| A Study to Characterize the Pharmacokinetics and Effect of Food on JNJ-31001074 in Healthy Volunteers (NCT00915434) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-06-01 |
| A Pilot Study of Bevacizumab for Neoplastic Meningitis (NCT00924820) | M.D. Anderson Cancer Center | 2009-06-01 |
| Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer (NCT00946673) | Stanford University | 2009-06-01 |
| Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model (NCT01040598) | O & O Alpan LLC | 2009-06-01 |
| A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy Volunteers (NCT01692834) | NeuroVive Pharmaceutical AB | 2009-06-01 |
| Examining Hair to Determine Tenofovir Exposure (NCT00903084) | Public Health Foundation Enterprises, Inc. | 2009-06-01 |
| Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS) (NCT00953485) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2009-06-01 |
| First-in-Human Single Ascending Subcutaneous (s.c.) Dose and Single Oral Dose of GLPG0187 (NCT00928343) | Lakefront Biotherapeutics NV | 2009-06-01 |
| Effects of Oxybutynin Topical Gel on Gastric Emptying (NCT00926926) | Watson Pharmaceuticals | 2009-06-01 |
| Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors (NCT00925275) | Cellectar, Inc | 2009-06-01 |
| Pharmacokinetics and Pharmacodynamics of Higenamine in Chinese Healthy Subjects (NCT01451229) | Peking Union Medical College Hospital | 2009-06-01 |
| A Supervised Nutritional Program in Pregnancies and NF-κB Expression in Placenta (NCT01667939) | Materno-Perinatal Hospital of the State of Mexico | 2009-06-01 |
| Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme (NCT00919737) | Nobelpharma | 2009-06-01 |
| Study to Evaluate the Effect of Food Intake on the Plasma Concentration Changes of Quetiapine After Oral Administration of FK949E in Healthy Volunteers (NCT01871987) | Astellas Pharma Inc | 2009-06-01 |
| Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers (NCT01079286) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2009-06-01 |
| A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (NCT00916227) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2009-06-01 |
| Safety and Tolerability Study of BIBF 1120 as Intravenous Infusion and Absolute Bioavailability of BIBF 1120 as Soft Gelatine Capsule in Healthy Subjects (NCT02182258) | Boehringer Ingelheim | 2009-06-01 |
| Topical Estriol for Vaginal Health (NCT00908570) | Gynuity Health Projects | 2009-06-01 |
| Evaluate the Pharmacokinetics of Quetiapine Fumarate in Chinese Schizophrenic Patients (NCT00919607) | AstraZeneca | 2009-06-01 |
| Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma (NCT00918333) | Mayo Clinic | 2009-06-01 |
| Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma (NCT00903968) | Dana-Farber Cancer Institute | 2009-06-01 |
| An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis (NCT01384162) | Newron Sweden AB | 2009-06-01 |
| Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC) (NCT00943176) | Mayo Clinic | 2009-06-01 |
| Study of the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine (NCT00800670) | McMaster University | 2009-06-01 |
| Pharmacokinetics of Itraconazole in Pediatric Cancer Patients (NCT01409018) | Seoul National University Hospital | 2009-06-01 |
| A Study of Single Dose of ABT-333 in Healthy Male Adults (NCT00919490) | Abbott | 2009-06-01 |
| Efficacy and Safety of Filgrastim in Alzheimer's Disease (NCT01617577) | University of South Florida | 2009-06-01 |
| VA106483 Dose Response Study in Elderly Males (NCT00922740) | Vantia Ltd | 2009-06-01 |
| Interaction Study of Clopidogrel 600/150 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects (NCT01129414) | Sanofi | 2009-06-01 |
| Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme (NCT00904852) | Millennium Pharmaceuticals, Inc. | 2009-06-01 |
| First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid Arthritis (NCT00927927) | Janssen Research & Development, LLC | 2009-06-01 |
| Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration (NCT00878436) | NYU Langone Health | 2009-06-01 |
| Vitamin E Supplements in Treating Patients Undergoing Surgery for Colorectal Cancer (NCT00905918) | Rutgers, The State University of New Jersey | 2009-06-01 |
| Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B) (NCT00897390) | AstraZeneca | 2009-06-01 |
| A Phase I Study of Famitinib Malate in Patients With Solid Tumor (NCT01762280) | Jiangsu HengRui Medicine Co., Ltd. | 2009-06-01 |
| Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer (NCT00910000) | Dana-Farber Cancer Institute | 2009-06-01 |
| Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II) (NCT00900627) | AstraZeneca | 2009-06-01 |
| Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00918723) | Fred Hutchinson Cancer Center | 2009-06-01 |
| Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer (NCT00887575) | SCRI Development Innovations, LLC | 2009-06-01 |
| Study With Atu027 in Patients With Advanced Solid Cancer (NCT00938574) | Silence Therapeutics GmbH | 2009-06-01 |
| Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy (NCT00967629) | Icahn School of Medicine at Mount Sinai | 2009-06-01 |
| Bioequivalence Study Comparing Artesunate Tablet To Arsuamoon® Tablets (Guilin-China) In Healthy Subjects (NCT00894374) | Pfizer | 2009-06-01 |
| A Vaccine Study for High Risk Cancers (NCT00944580) | Penn State University | 2009-06-01 |
| Safety Study of FLP Injection to Treat Tumor Patients (NCT01361529) | Acea Bio (Hangzhou) Co., Ltd. | 2009-06-01 |
| Safety Study of MPC-3100 in Cancer Patients Who Have Failed Other Treatments (NCT00920205) | Myrexis Inc. | 2009-06-01 |
| Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes (NCT00924053) | Theracos | 2009-06-01 |
| Clinical Evaluation of the New Hypoxia Imaging Agent HX4 (NCT01213030) | Siemens Molecular Imaging | 2009-06-01 |
| Relative Bioavailability of Single Doses of Dabigatran Etexilate When Administered Alone or in Combination With a Single Dose of Ketoconazole or in Combination With q.d. Ketoconazole at Steady State in Healthy Male and Female Volunteers (NCT02170675) | Boehringer Ingelheim | 2009-06-01 |
| Treadmill Training With Lower Extremity Amputees (NCT01419288) | Stony Brook University | 2009-06-01 |
| A Phase 1 Trial To Assess The Safety And Pharmacokinetics Of Single, Ascending, Oral Doses Of Dimebon In Healthy Adults (NCT00907322) | Pfizer | 2009-06-01 |
| Staccato Loxapine Pulmonary Safety in Patients With COPD (NCT00889837) | Alexza Pharmaceuticals, Inc. | 2009-06-01 |
| Role of Endogenous Estrogen in Growth-Hormone Regulation in Postmenopausal Women (NCT01186796) | Mayo Clinic | 2009-06-01 |
| VX-950-TiDP24-C132: A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Telaprevir. (NCT00903773) | Tibotec BVBA | 2009-06-01 |
| A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma (NCT00934440) | University of Kansas Medical Center | 2009-06-01 |
| Relative Bioavailability of Single Doses of Dabigatran Etexilate in Healthy Volunteers (NCT02173717) | Boehringer Ingelheim | 2009-06-01 |
| PERVIDEO I Registry, The Lutonix Paclitaxel-Coated Balloon Catheter for the Treatment of Coronary In-Stent Restenosis (NCT00916279) | C. R. Bard | 2009-06-01 |
| Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab (NCT00932438) | University of Louisville | 2009-06-01 |
| Studying Different Formulations of SR13668 in Healthy Volunteers (NCT00896207) | National Cancer Institute (NCI) | 2009-06-01 |
| Pharmacokinetics of Oral Thiamine (NCT01433952) | Baystate Medical Center | 2009-06-01 |
| AZD6088 Single Ascending Dose Study (NCT00931541) | AstraZeneca | 2009-06-01 |
| Bioavailability of BI 10773 and Pioglitazone in Healthy Male Volunteers (NCT02276365) | Boehringer Ingelheim | 2009-06-01 |
| Safety of VAX102 Vaccine Given With Seasonal Flu Vaccine in Healthy Adults (NCT00921973) | VaxInnate Corporation | 2009-06-01 |
| Phase 1/2a Study of DTA-H19 in Advanced Stage Ovarian Cancer (NCT00826150) | Anchiano Therapeutics Israel Ltd. | 2009-06-01 |
| A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects (NCT00894660) | Pfizer | 2009-06-01 |
| Study to Investigate Safety With Special Emphasis on ECG Effects and Tolerability After Oral Doses of Dextromethorphan Hydrobromide Monohydrate in Healthy Male and Female Subjects (NCT02191176) | Boehringer Ingelheim | 2009-06-01 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Liposomal siRNA in Subjects With High Cholesterol (NCT00927459) | Arbutus Biopharma Corporation | 2009-06-01 |
| Growth Factor Signature (GFS) Pilot Study (MK0000-098)(COMPLETED) (NCT00860535) | Merck Sharp & Dohme LLC | 2009-06-01 |
| MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia (NCT00911066) | Millennium Pharmaceuticals, Inc. | 2009-06-01 |
| Renal Mechanism of Action/Splay vs. TmG (NCT00726505) | AstraZeneca | 2009-06-01 |
| Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs (NCT00920088) | GlaxoSmithKline | 2009-06-01 |
| A Study To Assess The Effect Of PF-03526299 On Lung Function Following An Allergen Challenge In Asthmatic Subjects (NCT00877539) | Pfizer | 2009-06-01 |
| Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants (NCT00854633) | Agennix | 2009-06-01 |
| Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic Patients (NCT00935220) | Boehringer Ingelheim | 2009-06-01 |
| Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer (NCT00921661) | Sanofi | 2009-06-01 |
| QTc Study of Rosi XR in Healthy Volunteers (NCT00884533) | GlaxoSmithKline | 2009-06-01 |
| A Phase I Study to Assess the Safety, Pharmacokinetics, and Potential Effects of Amrubicin on the QT/QTc Interval in Cancer Patients With Advanced Solid Tumors. (NCT00915083) | Celgene | 2009-06-01 |
| Study to Assess the Safety and Tolerability of AZD1152 in Combination With Low Dose Cytosine Arabinoside (LDAC) (NCT00926731) | AstraZeneca | 2009-06-01 |
| Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma (NCT00734864) | Annick Desjardins | 2009-06-01 |
| Metabolism and Pharmacokinetics of Oral Solution of [14C]-BI 201335 in Healthy Male Volunteers (NCT02182349) | Boehringer Ingelheim | 2009-06-01 |
| Effect of Repeated Administration of Eslicarbazepine Acetate on the Pharmacokinetics of Simvastatin in Healthy Subjects (NCT00987558) | Bial - Portela C S.A. | 2009-06-01 |